A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies - BeOne

A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies

BeOne Study ID

BGB-3111-216

ClinicalTrials.gov ID

NCT04052854

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents